New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BBY;SAM;CLWR;S;CVS;RIGL;ENDP;YELP;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
December 16, 2014
09:36 EDTAAPLActive equity options trading
Active equity options trading according to Track Data: AAPL AMZN C TSLA PBR TWTR NFLX JPM CLF ABX
08:58 EDTENDPEndo a top pick for 2015, says Sterne Agee
Subscribe for More Information
08:51 EDTCVSCVS Health affirms 'steady state' targets for 2013-18
Subscribe for More Information
08:32 EDTSAM, SAMBoston Beer upgraded to Buy from Outperform at CLSA
Subscribe for More Information
08:27 EDTCVSCVS Health sees Q1 adjusted EPS $1.06-$1.09, consensus $1.15
Subscribe for More Information
08:21 EDTCVSCVS Health sees tobacco exit continuing to dilute FY15 profits, as expected
CVS Health sees an annual impact from its tobacco exit of $2B in lost revenues, including $1.5B from tobacco and the rest from basket, and 17c per share impact to FY15 EPS, compared to about 8c in 2014. CVS sees an incremental impact in 2015 from its tobacco exit of $1.1B in lost revenues and between 8c-9c per share in EPS, which will be front-half loaded. CVS noted that the year-over -year impact from the exit will be fully wrapped by Q4. CVS said the cadence of its 2015 profit growth should be significantly back-half weighted, citing the tobacco exit, the timing of break-open generics, the benefits from Red Oak Sourcing and other factors.
08:17 EDTCVSCVS Health sees FY15 PBM revenue up 11%-12.25%
Subscribe for More Information
08:00 EDTCVSCVS Health sees FY15 retail SSS down 0.5% to up 0.75%
Subscribe for More Information
07:58 EDTCVSCVS Health sees FY15 revenue up 7%-8.25%, consensus $146.09B
Subscribe for More Information
07:55 EDTCVSCVS Health backs FY14 adjusted EPS view $4.47-$4.50, consensus $4.50
Subscribe for More Information
07:36 EDTCVSCVS Health sees FY15 free cash flow $5.9B-$6.2B
CVS Health expects to generate free cash flow of $5.9B-$6.2B in 2015, and cash from operations of $7.6B-$7.9B in 2015. This guidance assumes the completion of $6B in share repurchases during 2015. "We've established a solid track record of delivering on our promises, and our results prove that out. Looking ahead, we are targeting solid, long-term enterprise growth and expect to generate a significant amount of cash that will be available to enhance returns. Some of that cash will be used to invest in the business, such as through strategic, bolt-on acquisitions that drive continued share gains. The rest will be returned to our shareholders through dividends and value-enhancing share repurchases," said CFO Dave Denton.
07:35 EDTCVSCVS Health adds $10B to share repurchase plan, boosts dividend 27%
CVS Health announced that its board of directors approved a 27% increase in its quarterly cash dividend, to 35c per share on the common stock of the company. This increase translates to $1.40 per share annually, up 30c per share, and keeps the company solidly on track to meet its 2018 dividend payout ratio target of 35%. The quarterly dividend is payable on February 2 to holders of record on January 22. In addition, the company announced that its board of directors approved a new share repurchase program for up to $10B of the company's outstanding common stock, which is effective immediately and is expected to be completed over a multi-year period, permits the company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. Combined with approximately $2.7B that remains on the share repurchase program approved by the board of directors in December of 2013, this new $10B share repurchase authorization makes available a total of approximately $12.7B for share repurchases.
07:33 EDTCVSCVS Health sees FY15 adjusted EPS $5.05-$5.19, consensus $5.11
07:32 EDTCVSCVS Health announces $10B share repurchase plan, boosts dividend 27%
06:48 EDTAAPLMore companies adopting Apple Pay, NY Times says
Subscribe for More Information
06:32 EDTAAPLApple, Samsung offer price cuts for tablet products, DigiTimes reports
Subscribe for More Information
06:16 EDTAAPLGT Advanced's settlement with Apple approved by bankruptcy court, WSJ reports
Subscribe for More Information
December 15, 2014
16:36 EDTAAPLOn The Fly: Closing Wrap
The Dow began the session with triple digit gains, but the move was short lived and so was the positive start for the equities market, which tumbled with oil prices and struggled for the remainder of the session. The day’s economic reports, which included the Empire Manufacturing report, industrial production and capacity utilization reports, and the NAHB housing market index, had little effect on the market. Stocks recovered a bit but did not get back into the green before the close, with investors wondering how the Fed, which begins its final FOMC meeting of the year tomorrow, will view its strategy in light of the recent weakness in oil. ECONOMIC EVENTS: In the U.S., the Empire State manufacturing index fell to -3.6 in December, which was significantly worse than the expectation for it to rise to 12.4 from its prior 10.2 reading. Industrial production jumped 1.3% in November, which was better than the expected 0.7% increase. The NAHB homebuilder sentiment index fell one point to 57 in December, versus expectations for a one point rise to a 59 reading. Near noon, WTI crude was down more than 2% and was trading below $57 per barrel. COMPANY NEWS: Riverbed Technology (RVBD) rose $1.57, or 8.38%, to $20.31 after the company agreed to be acquired by private equity investment firm Thoma Bravo and the private investor department of Ontario Teachers’ Pension Plan. Riverbed stockholders will receive $21 per share in cash, or a total of approximately $3.6B, which Wells Fargo views as a "good decision" and good deal for the company given the challenges in its business... PetSmart (PETM) advanced $3.30, or 4.25%, to $80.97 after the company agreed to be acquired by a consortium led by BC Partners at a price of $83.00 per share in cash. However, the private equity backers of Petco that were not allowed to participate in the auction process because of competition concerns, Leonard Green & Partners and TPG, could still make a rival offer, according to The Deal Pipeline, citing a source familiar with the situation. MAJOR MOVERS: Among the notable gainers was Sorrento Therapeutics (SRNE), which advanced $1.50, or 25.86%, to $7.30 after the company announced that it has entered into a binding agreement with NantWorks founder Dr. Patrick Soon-Shiong to establish a strategic collaboration to jointly develop next generation immunotherapies for the treatment of cancer and auto-immune diseases. Also higher was Cirrus Logic (CRUS), which rallied $4.12, or 21.87%, to $22.96 after Barclays upgraded the stock two notches to Overweight from Underweight and said the company is poised to make significantly more money per each iPhone sold next year. Among the noteworthy losers was CGG SA (CGG), which was downgraded to Underperform at Raymond James and dropped $2.41, or 28.29%, to $6.11 after Technip (TKPPY) said that it does not plan to file a tender for the company after talks between the companies did not result in a deal. Also lower were shares of Habit Restaurants (HABT), which fell $7.20, or 17.19%, to $34.69 as analysts rolled out coverage of the stock following its IPO about a month ago. Amid the coverage initiations, Habit Restaurants shares were initiated with a Neutral and $41 price target at RW Baird, with a Market Perform rating at Wells Fargo, with an Equal Weight at Stephens and with an Overweight rating and $48 target at Piper Jaffray. INDEXES: The Dow fell 99.99, or 0.58%, to 17,180.84, the Nasdaq dropped 48.44, or 1.04%, to 4,605.16, and the S&P 500 declined 12.70, or 0.63%, to 1,989.63.
16:00 EDTAAPLOptions Update; December 15, 2014
Subscribe for More Information
12:26 EDTCVSCVS Health volatility increases into analyst day
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use